Prelude Therapeutics
PRLD
PRLD
62 hedge funds and large institutions have $119M invested in Prelude Therapeutics in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 22 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less capital invested
Capital invested by funds: $235M → $119M (-$117M)
Holders
62
Holding in Top 10
–
Calls
$2.15M
Puts
–
Top Buyers
| 1 | +$629K | |
| 2 | +$570K | |
| 3 | +$514K | |
| 4 |
D.E. Shaw & Co
New York
|
+$482K |
| 5 |
CANY
Caxton Associates (New York)
New York
|
+$438K |
Top Sellers
| 1 | -$5.58M | |
| 2 | -$2.73M | |
| 3 | -$866K | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$490K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$420K |